secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eton Pharmaceuticals, Inc. (ETON)
CIK:        0001710340
Form:       8-K
Filed at:   2022-04-11T23:59:59+00:00
Accession:  0001493152-22-009587
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eton Pharmaceuticals appoints James Gruber as CFO; Wilson Troutman retires
--------------------------------------------------------------------------

- James Gruber appointed CFO, Treasurer, Secretary effective April 11, 2022.
- Gruber previously U.S. Controller at Horizon Therapeutics for 7 years.
- Wilson Troutman retired as CFO, will assist transition through May 31, 2022.
- Gruber receives $350K base salary, 40% target bonus, option for 100,000 shares vesting over 4 years.
- Company owns or receives royalties from six FDA-approved products, four more submitted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710340/000149315222009587/0001493152-22-009587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710340/000149315222009587/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-009587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer